3
Registered trials
1
Recruiting
3
Unique sponsors
5
Unique IMPs
0
Commercial trials
Drug classes (ATC)
—
ATC code not specified
1
L
Oncology (ATC L)
2
Mechanism of action (INN-stem analysis)
Unknown / small molecule
2 substances
mTOR inhibitor
1 substance
Kinase inhibitor
1 substance
Topoisomerase II inhibitor
1 substance
Phase I/II:
1
Phase I (Other):
2
Phase I/II
1 trial-
RecruitingAssistance Publique Hopitaux De Paris AcademicAXITINIB; ETOPOSIDE
Phase I (Other)
2 trials-
EndedFundacion Para La Investigacion Biomedica Hospital Infantil Universitario Nino Jesus AcademicALLOGENIC BONE MARROW-DERIVED MESENCHYMAL STEM CELLS TRANSDUCED WITH ICOVIR-5, EX VIVO EXPANDED
-
PendingInstytut Pomnik Centrum Zdrowia Dziecka Academic7,8-DIBROMO-5,6-DIHYDRO-9-METHYL-2-(1-PIPERAZINYL)-4H-IMIDAZO[4,5,1-IJ]QUINOLINE HYDROCHLORIDE; EVEROLIMUS
Sponsor activity
| Sponsor | Type | Trials | Phases | Recruiting |
|---|---|---|---|---|
| Fundacion Para La Investigacion Biomedica Hospital Infantil Universitario Nino Jesus | Academic | 1 | Phase I (Other) | 0 |
| Instytut Pomnik Centrum Zdrowia Dziecka | Academic | 1 | Phase I (Other) | 0 |
| Assistance Publique Hopitaux De Paris | Academic | 1 | Phase I/II | 1 |
New trials by year
2021
1
2024
1